ZERO AF Study: Clinical Trials

Clinical Evaluation of the Blazer Open-Irrigated Ablation Catheter for the Treatment of Paroxysmal Atrial Fibrillation (ZERO-AF)

This study is currently recruiting participants. For more information on participating centers in your area, please go to

Verified May 2013 by Boston Scientific Corporation
Sponsor: Boston Scientific Corporation 
Information provided by (Responsible Party): Boston Scientific Corporation Identifier: NCT01687166
First received: August 29, 2012
Last updated: October 24, 2013
Last verified: May 2013 

For more information, visit:


Bryan Wylie
Clinical Trial Manager
(408) 935-6166

Lynnett Voshage-Stahl
Director of Clinical Affairs

Return to the ZERO AF Study main page